Concepedia

Gregory Koch

GK

8

Publications

3.7K

Citations

8

H-Index

1992

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Gregory Koch is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicine, and pharmacology.

Top concepts

MedicineDrug DiscoveryPharmacologyImmunologyBiochemistryBiosynthesisPhysiologyEngineeringData ScienceMetabolomics

Publications per year

1992–2015

8

Publications

8

Siamese Neural Networks for One-shot Image Recognition

Gregory Koch, Richard S. Zemel, Ruslan Salakhutdinov · 2015 · 3.2K citations

Few-shot Learning, Convolutional Neural Network, Engineering +16

Potent, orally absorbed glucagon receptor antagonists

Stephen E. de Laszlo, Candice Hacker, Bing Li et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 169 citations · Full text

G Protein-coupled Receptor, Medicine, Functional Selectivity +5

Characterization of a Novel, Non-peptidyl Antagonist of the Human Glucagon Receptor

Margaret A. Cascieri, Gregory Koch, Elżbieta Ber et al. · Journal of Biological Chemistry · 1999 · 92 citations · Full text

Quinoxapeptins: Novel Chromodepsipeptide Inhibitors of HIV-1 and HIV-2 Reverse Transcriptase. I. The Producing Organism and Biological Activity.

Russell B. Lingham, Amy Hsu, JULIE A. O' BRIEN et al. · The Journal of Antibiotics · 1996 · 52 citations

Discovery of structurally diverse natural product antagonists of chemokine receptor CXCR3

John G. Ondeyka, Kithsiri Herath, Hiranthi Jayasuriya et al. · Molecular Diversity · 2005 · 50 citations

Chemokine Receptor Cxcr3, Medicine, Immunology +6

Rows per page

1–5 of 8